LogoLogoLogoLogo
  • Team
  • Investors & Media
  • Government
    • Policies
  • Contact
  • Team
  • Investors & Media
  • Government
    • Policies
  • Contact
Synaptogenix | kevintreed
2
archive,author,author-kevintreed,author-2,wp-theme-stockholm,ajax_fade,page_not_loaded,,select-theme-ver-4.4,wpb-js-composer js-comp-ver-5.4.7,vc_responsive
February 7, 2018 In Press Release

Neurotrope to Present at BIO CEO & Investor Conference

...

January 25, 2018 In Press Release

Neurotrope to Present at NobleCon 14th Annual Institutional Investor Conference

...

January 5, 2018 In Press Release

Neurotrope’s Bryostatin Improves Cognition in Patients with Advanced Alzheimer’s Disease Based on Further Analysis of Phase 2 Clinical Trial Data

...

February 11, 2016 In Press Release

Neurotrope Doses First Patients in Phase 2b Study of Bryostatin for Treatment of Severe Alzheimer’s Disease

...